Allergic Rhinitis Due to Pollen

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Allergic Rhinitis Due to Pollen trials you may qualify for

100

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 14 trials

RecruitingNot Applicable

NCT07055542

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

Thunderstorm asthma is a recurring public health emergency in South-Eastern Australia which occurs in springtime. The major identified risk factors for thunders…

Australia530 participantsStarted 2025-08-27

Treatment: Observational

RecruitingNot Applicable

NCT04544774

The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy

This prospective multicentric academic NAPT study aims to compile a database of all patients who initiate immunotherapy. The NAPT will take place before, durin…

Belgium200 participantsStarted 2020-07-16

Treatment: AIT, NAPT

RecruitingPhase 2

NCT07398859

Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis

This study is a multicenter, open-label, Phase II, single-arm clinical trial, with a planned enrollment of 200 to 300 subjects. Its primary objective is to eval…

China300 participantsStarted 2026-03-19

Treatment: TQH2722 injection

RecruitingNot Applicable

NCT07412990

GRASS (Grass MATA MPL Real-world Assessment Study)

Objective of this non-interventional study (NIS) is to collect data on the use of Grassmuno® in routine clinical practice.

Germany1,000 participantsStarted 2026-03-11

Treatment: Grassmuno®

RecruitingPhase 3

NCT07309432

Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy

This study is researching 2 experimental drugs, REGN5713 and REGN5715. The study drugs will be either of these drugs given alone (either REGN5713 or REGN5715) o…

United States350 participantsStarted 2026-01-10

Treatment: REGN5713, REGN5715

RecruitingPhase 2

NCT07219849

A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Und…

This study aims to evaluate the effectiveness and safety of ALDP001 Nasal Spray in treating seasonal allergic rhinitis, and to identify the optimal dosage and a…

Canada164 participantsStarted 2025-10-17

Treatment: ALDP001 Nasal Spray, Placebo Nasal spray

All recent trials (100 shown)

Not Yet RecruitingPhase 2

NCT07563439

PollenVax Subcutaneous Immunotherapy for Mugwort Pollen-Induced Allergic Rhinitis

This study evaluates the effectiveness and safety of PollenVax, a subcutaneous allergen immunotherapy (SCIT) drug developed for the treatment of allergic rhinit…

Kazakhstan138 participantsStarted 2026-05-01

Treatment: Recombinant Artemisia vulgaris allergen Art v 1 with Montanide ISA-51 adjuvant, Montanide ISA-51 placebo emulsion

CompletedPhase 2/3

NCT04687059

An Exploratory Study of PQ Grass 27600 SU

PQGrass309 is aimed at exploring the expected average treatment effect of PQ Grass 27600 SU cumulative dose on symptom and medication score in a field setting.…

United States119 participantsStarted 2020-10-19

Treatment: PQ Grass, Active Placebo

Allergic Rhinitis Due to Pollen

Trial phase breakdown

Trial status

Actively recruiting — 14 trials

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy

Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis

GRASS (Grass MATA MPL Real-world Assessment Study)

Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy

A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Und…

All recent trials (100 shown)

PollenVax Subcutaneous Immunotherapy for Mugwort Pollen-Induced Allergic Rhinitis

An Exploratory Study of PQ Grass 27600 SU

Trial phase breakdown

Trial status

Actively recruiting — 14 trials

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

The Role of the Nasal Allergen Provocation Test in Starting and Monitoring Allergen Immunotherapy

Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis

GRASS (Grass MATA MPL Real-world Assessment Study)

Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy

A Study to Determine the Optimal Dose and Frequency of ALDP001 Nasal Spray in Adults With Seasonal Allergic Rhinitis Und…

All recent trials (100 shown)

PollenVax Subcutaneous Immunotherapy for Mugwort Pollen-Induced Allergic Rhinitis

An Exploratory Study of PQ Grass 27600 SU

Study of DM-101PX in Adults With Birch Pollen Allergy

Grass Pollen Immunotherapy Plus Dupilumab for Tolerance Induction

A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants W…

Special Drug Use Observational Study of Xolair in Patients With Severe to Most Severe Seasonal Allergic Rhinitis Aged ≥…

A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis (SAR)

M-Gard Particulate EW Efficacy Study on Seasonal Allergic Rhinitis

A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Seasonal Allergic Rhinitis

Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis

Tyrosine Allergoid Paediatric and Adult Study

Tezepelumab in Allergic Rhinitis and Asthma Study (TEZARS)

Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.

Study of Efficacy and Safety of Omalizumab in Severe Japanese Cedar Pollinosis Adult and Adolescent Patients

Phase I Study of PollenVax in Patients With Mugwort Pollen-Induced Allergic Rhinitis

Efficacy and Safety of LP-003 Injection in Patients With Moderate to Severe Seasonal Allergic Rhinitis

Efficacy and Safety of LP-003 in Moderate-to-severe Seasonal Allergic Rhinitis Adult

A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients

Identification of B Regulatory Cells by Flow Cytometry

Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma